Kainan Lin

Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

NAT10/ac4C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling.

NAT10/ac4C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 14, 2026

Single-Cell and Bulk Transcriptomics Uncover the Cellular Ecosystem of Vascular Invasion in Intrahepatic Cholangiocarcinoma.

Single-Cell and Bulk Transcriptomics Uncover the Cellular Ecosystem of Vascular Invasion in Intrahepatic Cholangiocarcinoma.

Journal: Cells
Published: April 17, 2026

A pyroptosis-related molecular signature stratifies prognosis and highlights GSDMB-mediated malignancy in intrahepatic cholangiocarcinoma.

A pyroptosis-related molecular signature stratifies prognosis and highlights GSDMB-mediated malignancy in intrahepatic cholangiocarcinoma.

Journal: Biology direct
Published: March 11, 2026

An Immune Gene Signature Stratifies Breast Cancer Prognosis Through iCAF-Driven Immunosuppressive Microenvironment.

An Immune Gene Signature Stratifies Breast Cancer Prognosis Through iCAF-Driven Immunosuppressive Microenvironment.

Journal: Biomedicines
Published: October 08, 2025

Haplotype-resolved genomes of Trichophyton mentagrophytes and Trichophyton tonsurans.

Haplotype-resolved genomes of Trichophyton mentagrophytes and Trichophyton tonsurans.

Journal: Scientific data
Published: October 22, 2024

Deciphering alternative splicing patterns during cell fate transition of fast chemical reprogramming.

Deciphering alternative splicing patterns during cell fate transition of fast chemical reprogramming.

Journal: BMC biology
Published: September 19, 2024

Screening of PDSS1 as a Potential Biomarker for Hepatocellular Carcinoma Based on a Copper-Related Prognostic Signature through Bulk and Single-cell RNA-sequencing Analysis.

Screening of PDSS1 as a Potential Biomarker for Hepatocellular Carcinoma Based on a Copper-Related Prognostic Signature through Bulk and Single-cell RNA-sequencing Analysis.

Journal: Journal of Cancer
Published: April 01, 2024

Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers.

Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 22, 2024

Erratum to "Research trends in cholangiocarcinoma treatments during the last 3 decades" [Heliyon 9(7) (July 2023) e17100].

Erratum to "Research trends in cholangiocarcinoma treatments during the last 3 decades" [Heliyon 9(7) (July 2023) e17100].

Journal: Heliyon
Published: August 23, 2023

Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation.

Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 17, 2023

Research trends in cholangiocarcinoma treatments during the last 3 decades.

Research trends in cholangiocarcinoma treatments during the last 3 decades.

Journal: Heliyon
Published: April 06, 2023
Showing 1-11 of 11

Last Updated: 09/26/2026